Physician assistants are assuming a greater role in patient care in the US health system. The objective of this study was to examine attitudes and beliefs about diabetes among physician assistant trainees.
METHODS
A survey of 3 currently enrolled classes of physician assistant students was conducted using the Diabetes Attitude Survey (DAS, version 3). An additional question was presented to gather information about the level of hyperglycemia at which students would intensify diabetes therapy.
RESULTS
On average, students scored high on all subscales, indicating general agreement with the attitudes examined by the DAS. For 3 subscales (seriousness of type 2 diabetes, value of tight glucose control, and patient autonomy), significant differences were seen across year of training. When asked about the level of glucose control at which they would advance therapy, a wide range of responses occurred, with some being out of target.
CONCLUSIONS
Physician assistant students had favorable attitudes regarding type 2 diabetes. However, deficits appear to exist in understanding when to advance therapy. More studies on physician assistant students' knowledge of diabetes standards of care are required.
Get full access to this article
View all access options for this article.
References
1.
1. Cooper RA, Henderson T, Dietrich CL. Roles of nonphysician clinicians as autonomous providers of patient care. JAMA. 1998;280:795-802.
2.
2. Jones PE, Cawley JF. Physician assistants and health system reform. Clinical capabilities, practice activities, and potential roles. JAMA. 1994; 271:1266-1272.
3.
3. Cooper RA. The growing independence of nonphysician clinicians in clinical practice. JAMA. 1997;277:1092-1093.
4.
4. White D. Physician assistants as partners in physiciandirected care. South Med J. 1999;92:956-960.
5.
5. Cooper RA. Perspectives on the physician workforce to the year 2020. JAMA. 1995;274: 1534-1543.
6.
6. Becker DM, Raqueno JV, Yook RM, et al. Nurse-mediated cholesterol management compared with enhanced primary care in siblings of individuals with premature coronary disease. Arch Intern Med. 1998; 158:1533-1539.
7.
7. Aubert RE, Herman WH, Waters J, et al. Nurse case management to improve glycemic control in diabetic patients in a health maintenance organization. A randomized, controlled trial. Ann Intern Med. 1998:129:605-612.
8.
8. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care. 1999; 22:S32-S41.
9.
9. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. N Engl J Med. 1993;329: 977-986.
10.
10. United Kingdom Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with mefformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352:854-865.
11.
11. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology. 1981;88: 583-600.
12.
12. Litzelman DK, Slemenda CW, Langefeld CD, et al. Reduction of lower extremity clinical abnormalities in patients with non-insulin-dependent diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1993;119:36-41.
13.
13. Ravid M, Brosh D, Levi Z. Bar-Dayan Y, Ravid D, Rachmani R. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial. Ann Intern Med. 1998;128:982-988.
14.
14. Harris MI, Eastman RC, Cowie CC, Flegal KM, Eberhardt MS. Racial and ethnic differences in glycemic control of adults with type 2 diabetes. Diabetes Care. 1999; 22:403-408.
15.
15. General Accounting Office. Medicare: most beneficiaries with diabetes do not receive recommended monitoring services. Washington, DC: General Accounting Office; 1997:97-97.
16.
16. Fain JA, Melkus GD. Nurse practitioner practice patterns based on standards of medical care for patients with diabetes. Diabetes Care. 1994;17: 879-881.
17.
17. Larme AC, Pugh JA. Attitudes of primary care providers toward diabetes: barriers to guideline implementation. Diabetes Care. 1998;21: 1391-1396.
18.
18. Donnelly MB, Anderson RM. The role-related attitudes of physicians, nurses, and dieticians in the treatment of diabetes. Med Care. 1990;28: 175-179.
19.
19. Anderson RM, Donnelly MB, Davis WK. Controversial beliefs about diabetes and its care. Diabetes Care. 1992;15: 859-863.
20.
20. Saad JA, Pirie P, Sprafka M. Relationship between flexible sigmoidoscopy training during residency and subsequent sigmoidoscopy performance in practice. Fam Med. 1994;26:250-253.
21.
21. Weinberger M, Cohen SJ, Mazzuca SA. The role of physicians' knowledge and attitudes in effective diabetes management. Soc Sci Med. 1984;19: 965-969.
22.
22. Anderson RM, Donnelly MB, Gorenflo DW, Funnell MM, Sheets KJ. Influencing the attitudes of medical students toward diabetes. Diabetes Care. 1993;16:503-505.
23.
23. Bernard AM, Anderson L, Cook CB, Phillips LS. What do internal medicine residents need to enhance their diabetes care?Diabetes Care. 1999;22: 661-666.
24.
24. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US: 1990-1998. Diabetes Care. 2000;23: 1278-1283.
25.
25. Anderson RM, Fitzgerald JT, Funnell MM, Gruppen LD. The third version of the Diabetes Attitude Scale. Diabetes Care. 1998;21:1403-1407.
26.
26. Janes GR. Ambulatory medical care for diabetes. In: Diabetes in America. 2nd ed.Bethesda, Md: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disorders; 1995. NIH publication 95-1468: 541-552.
27.
27. Powe ML, Hughes N. The role of physician assistants in the delivery of medical care. J Med Pract Manage. 1999;15: 73-76.
28.
28. Cook CB, El-Kebbi I, Gallina DL, Dunbar VG, Ernst KL, Phillips LS. Diabetes in urban African Americans XVI.
29.
29. Turner RC, Cull CA, Frighi V, Holman RR, United Kingdom Prospective Diabetes Study (UKPDS) Group. Glycemic control with diet, sulfonylurea, mefformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies. (UKPDS 49). JAMA. 1999;281:2005-2012.
